Eli Lilly has announced over 8 M&A deals since 2005, with the lead deals being the acquisition of Imclone Systems and Icos.
Abstracted from: Partnering Deals and Alliances with Eli Lilly
Eli Lilly seems to cycle through a period off active acquisition followed by periods of inactivity. This is probably due to the need to assimilate acquisitions into the corporate structure and adjust strategy as a consequence of such assimilation. Periods of inactivity normally follow a major acquisition as was the case after acquisition of Icos and Imclone Systems.
The following figure shows the level of Eli Lilly's M&A deals announcements since 2005.
Figure 1: Eli Lilly M&A deals 2005-2012
Source: Current Agreements, 2013
Eli Lilly has signed 9 M&A deals since 2005. Companies acquired include:
- Chemgen
- Avid Radiopharmaceuticals
- Alnara Pharmaceuticals
- Imclone Systems
- SGX Pharmaceutcials
- Hypnion
- Icos
View the full list at Current Agreements (subscription required)
Eli Lilly has been partially attracted to mega merger transactions whereby the company expands through the acquisition and assimilation of strategic target assets to realize business growth. This is evidenced by the acquisitions of Icos and Imclone Systems, the latter to get a strategic position in the biotech sector.
The following figure provides a summary of the top m&a deals by headline value.
Figure 2: Top Eli Lilly M&A deals by headline value 2005-2013
Source: Current Agreements, 2013
Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Eli Lilly
Eli Lilly M&A at Current Agreements
View all M&A deals for Eli Lilly: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005
Full details on each deal can be found at CurrentAgreements (subscription required)
Or purchase report: Partnering Deals and Alliances with Eli Lilly
More
Summary profile data for Eli Lilly
Partnering interests for Eli Lilly
Partnering activity for Eli Lilly
Available reports from Current Partnering
Report: Partnering Deals and Alliances with Eli Lilly
Report: Partnering Deals and Alliances with Big Pharma
Available resources for deal coverage for Eli Lilly
Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more
Read: more on Eli Lilly company profile, recent partnering, M&A and financing news and articles
Related
Report: Practical Guide to Finding Partners
Report: Partnering Deals and Alliances with Big Pharma
Report: Partnering Deals and Alliances with Eli Lilly
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now
Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk
